ReviewCureus2026
Perspectives on the Current Role of Radiation in the Management of Gastroesophageal Adenocarcinomas.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past two decades, management approaches for esophageal and gastroesophageal junction (GEJ) cancers have undergone a notable transformation, driven by clinical trials aimed at optimizing the use of surgery, chemotherapy, and chemoradiotherapy (CRT) in treatment. Landmark studies have confirmed the essential role of neoadjuvant CRT (nCRT) and perioperative chemotherapy compared with surgery alone in improving survival rates and pathological complete response (pCR). Recently, active surveillance has emerged as a safe alternative to immediate surgery, and in select patients, adjuvant immunotherapies have demonstrated enhanced efficacy while reducing complications. This review will discuss the data that have helped shape the current treatment landscape for esophageal and GEJ cancers, as well as potential future directions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.